# 3D Prediction of Patient-Specific Response

> **NCT03561207** · — · UNKNOWN · sponsor: **KIYATEC** · enrollment: 570 (estimated)

## Conditions studied

- Advanced Cancer
- Ovarian Cancer
- Glioblastoma Multiforme
- Anaplastic Astrocytoma

## Interventions

- **DIAGNOSTIC_TEST:** EV3D Assay

## Key facts

- **NCT ID:** NCT03561207
- **Lead sponsor:** KIYATEC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-11
- **Primary completion:** 2024-06
- **Final completion:** 2024-12
- **Target enrollment:** 570 (ESTIMATED)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03561207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03561207, "3D Prediction of Patient-Specific Response". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03561207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*